To hear about similar clinical trials, please enter your email below
Trial Title:
Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery
NCT ID:
NCT06512558
Condition:
Subclinical Breast Cancer Lesion
Conditions: Official terms:
Breast Neoplasms
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Additional MRI with gadolinium injection and 3D camera imaging
Description:
The study includes an additional MRI with gadolinium injection, performed in addition to
standard practice. In addition, 3D camera images will be acquired at the time of surgery.
Arm group label:
Interventional
Summary:
Breast cancer is diagnosed by imaging at a non-palpable stage in more than half of all
cases. Surgical removal requires preoperative guidance. Generally, preoperative guidance
is performed using a metal guide under local anaesthetic and radiological control. This
type of guidance has several limitations. For the patient, it can be painful and
traumatic. The procedure involves two departments: radiology and the operating theatre,
which poses logistical constraints. What's more, between 10% and 40% of patients require
repeat surgery for unhealthy margins, raising the question of the effectiveness of the
tracking procedure. The investigators propose to develop a non-invasive intraoperative
guidance system: Augmented Reality, which will provide a 3D vision with virtual
transparency of the breast during surgery, thanks to real-time fusion of preoperative
imaging with video from a camera located in the operating room. The process is
illustrated below.
Illustration of the general principle of the augmented reality system for locating
non-palpable breast lesions. The images above represent a preliminary test carried out on
the computer outside the operating room. This is an initial research prototype which has
not yet been validated and is not suitable for routine use.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Major women
- Requiring conservative surgical management of a subclinical cancerous breast lesion
(not palpable), the histology of which has been previously proven by
anatomopathology;
- Having a breast MRI indication at the time of the breast assessment performed at the
Centre Jean Perrin
- Ability to give informed consent to participate in the study,
- Membership of a social security scheme
Exclusion Criteria:
- Patients with breast neoplasia during pregnancy;
- Persons deprived of their liberty or under guardianship or incapable of giving
consent;
- Refusal to participate.
Gender:
Female
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
100 Years
Healthy volunteers:
No
Start date:
September 1, 2024
Completion date:
July 1, 2025
Lead sponsor:
Agency:
Centre Jean Perrin
Agency class:
Other
Source:
Centre Jean Perrin
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06512558